Evidence map›Paper›PMID 32652087›Full record

ArticleHuman pathology2020

Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome.

Wei Chen, Heather Hampel, Rachel Pearlman, Dan Jones, Weiqiang Zhao, Mohammed Alsomali, Deborah Knight, Wendy L Frankel

Open access · greenAbstract read
In one paragraph

Article in Human pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Guideline
  2. Characterisation of a Portuguese origin founder missense variant in MSH6.European journal of human genetics : EJHG · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Reply to Singh et al.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wei ChenDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Heather HampelDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Rachel PearlmanDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Dan JonesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Weiqiang ZhaoDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Mohammed AlsomaliDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Deborah KnightDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Wendy L FrankelDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: Wendy.Frankel@osumc.edu.
The Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

It has been observed that some patients with colorectal cancer due to germline or double somatic pathogenic variants in the mismatch repair (MMR) genes may have intact protein expression in their tumors as assessed by immunohistochemistry (IHC). This has been speculated to occur more frequently in Lynch syndrome (LS) cases due to pathogenic missense mutations, leading to expression of a full-length but nonfunctional protein with retained antigenicity. Our goals were to study the frequency of unexpected MMR expression in colorectal cancers among LS cases with missense mutations, LS cases with truncating mutations, as well as cases with double somatic MMR mutations and evaluate if the unexpected MMR expression is more common in certain categories. IHC slides were available for 82 patients with MMR deficiency without methylation, which included 56 LS cases and 26 double somatic MMR mutation cases. Sixteen of 82 MMR-defective cases showed unexpected MMR expression, with 10 cases showing tumor staining weaker than the control and 6 cases (7%) showing intact staining. Unexpected MMR expression was most commonly seen with LS cases with missense mutations (4 of 9, 44%), followed by MMR double somatic mutation cases (7 of 26, 27%), and finally by LS cases with truncating mutations (5 of 47, 11%). Cautious interpretation of MMR IHC is advised when dealing with tumor staining that is weaker than the control regardless of the percentage of tumor staining as these cases may harbor pathogenic MMR gene mutations. Missense mutations may account for some LS cases that may be missed by IHC alone. Strict adherence to proper interpretation of IHC with attention to staining intensity and the status of heterodimer partner protein will prevent many potential misses.

Indexed as

AdultAgedAged, 80 and overColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDNA Repair EnzymesFemaleHumansMaleMiddle AgedMutation, MissenseYoung AdultDNA Repair EnzymesColorectal cancerDouble somatic mutationImmunohistochemistryMismatch repair proteinMissense mutationMMR IHCUnexpected staining

Identifiers

PMID32652087
PMCPMC7664304
OpenAlexW3041840292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.